NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease

INTRODUCTION: This study is a European multicentre, randomised, double-blind, placebo-controlled trial investigating the efficacy and safety of nilvadipine as a disease course modifying treatment for mild-to-moderate Alzheimer's disease (AD) in a phase III study that will run for a period of 82...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lawlor, Brian, Kennelly, Sean, O'Dwyer, Sarah, Cregg, Fiona, Walsh, Cathal, Coen, Robert, Kenny, Rose Anne, Howard, Robert, Murphy, Caroline, Adams, Jessica, Daly, Leslie, Segurado, Ricardo, Gaynor, Siobhan, Crawford, Fiona, Mullan, Michael, Lucca, Ugo, Banzi, Rita, Pasquier, Florence, Breuilh, Laetitia, Riepe, Matthias, Kalman, Janos, Wallin, Anders, Borjesson, Anne, Molloy, William, Tsolaki, Magda, Olde Rikkert, Marcel
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2014
Gaiak:
Geriatric Medicine
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4194801/
https://ncbi.nlm.nih.gov/pubmed/25300460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-006364
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak